Clinical Features of Childhood Restless Legs Syndrome.

Sehyr Imran, Swati Jayaram, Maninder Kalra

Review Sleep medicine clinics 2025

<\/script>\n

`; }, get iframeSnippet() { const domain = 'sleepcited.com'; const params = 'pmid\u003D40348528'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style

Widget powered by . Free, no account required.

Abstract

Childhood restless legs syndrome is a sensori-motor disorder characterized by an irresistible urge to move the lower or upper extremities. It is usually accompanied by uncomfortable and unpleasant sensations in the legs which are worse at night. Symptoms worsen during periods of rest and improve with voluntary movement. The diagnosis can be facilitated by asking leading questions about symptoms, assessing their impact on sleep and daytime function, and by reviewing patient drawings of leg discomfort. Early recognition and management can improve daytime functioning and overall quality of life.

Zusammenfassung

Childhood restless legs syndrome is a sensori-motor disorder characterized by an irresistible urge to move the lower or upper extremities which is worse at night and worsening during periods of rest.

Used In Evidence Reviews

A Eisen für Restless-Legs-Syndrom

Clinical Features of Childhood Restless Legs Syndrome.

Embed This Widget

Abstract

Zusammenfassung

Used In Evidence Reviews

Similar Papers

Dopamine and iron in the pathophysiology of restless legs syndrome (RLS).

Restless legs syndrome and pregnancy.

Treatment of restless legs syndrome: an evidence-based review and implications for clinical practice.

Restless legs syndrome: pathophysiology, clinical presentation and management.

Altered brain iron homeostasis and dopaminergic function in Restless Legs Syndrome (Willis-Ekbom Disease).

Guidelines for the first-line treatment of restless legs syndrome/Willis-Ekbom disease, prevention and treatment of dopaminergic augmentation: a combined task force of the IRLSSG, EURLSSG, and the RLS-foundation.